Moreover, level of galectin 3 (GAL3), is increased in patients of pulmonary sarcoidosis (87) and fibrosis (88) and targeting GAL3 by small molecule inhibitors was showed efficacious in mouse models of bleomycin-induced lung fibrosis (89). Here, LGALS3 is linked to fibrosis.